Hospital and pharmaceutical prices are smothering America’s businesses — SkimNews

Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- U.S. health care spending is on pace to top $6 trillion this year, roughly $16,500 per person, with STAT's reporting identifying high prices — not volume of care — as the dominant driver of the country's outlier costs.
- Hospitals and drug companies use natural and human-made monopolies to bill employers and workers more than double what Medicare pays for identical services and medicines, according to research cited by STAT.
- Banner Health in Arizona initially quoted $232,000 for an outpatient knee surgery, refusing an $11,000 Medicare-reference payment from a car dealership employer; after pushback, Banner dropped the price to just under $50,000 — still nearly five times Medicare's rate.
- Sentara Health's flagship Norfolk General Hospital receives nearly $100,000 from Anthem's broad-network plan for a major joint replacement, compared with $28,000 from Medicare, and about $43,000 vs. roughly $14,000 for a pneumonia hospitalization.
- One unnamed hospital system entered Massachusetts contract negotiations demanding a 50% price increase over three years, far above the state's 3.6% cost-growth benchmark, according to Matt Veno of the Group Insurance Commission.
- Commercial insurers paid more than $2,500 on average for colonoscopies at Massachusetts hospital outpatient departments in 2023 — nearly two-thirds more than at independent surgery centers or physician offices performing the same procedure.
- Gerard Anderson of Johns Hopkins, co-author of landmark 2003 and 2019 papers, told STAT that employers and state policymakers are now signaling openness to government intervention to curb prices — an idea he said is normally 'anathema in the private sector.'
Why it matters: American employers — already writing checks for opaque hospital and drug bills — are now facing demands of 50% or more in contract negotiations, with common procedures billed at 2-3x Medicare rates. The Banner Health case shows even reference-based pricing arrangements fail to meaningfully constrain hospital pricing power, threatening the viability of employer-sponsored insurance for both firms and workers.
Ask SkimNews




